FORM OF LOCK-UP AGREEMENT
This Lock-Up Agreement (this “Agreement”) is entered into as of [Date] by and between Zeno42 Inc., a Delaware corporation (the “Company”), and Torsten Lankau, an individual (the “Stockholder”).
The Company proposes to list its common stock on The Nasdaq Stock Market through a direct listing (the “Direct Listing”). In connection with the proposed Direct Listing, and in consideration of the mutual covenants set forth herein, the parties agree as follows.
1. Covered Securities. “Covered Securities” means the securities identified on Schedule A and any securities of the Company issued or issuable with respect to them by reason of a stock split, stock dividend, combination, reclassification, recapitalization, exchange or similar transaction, including shares of common stock issued upon conversion of any preferred stock identified on Schedule A.
2. Lock-Up Period. The “Lock-Up Period” begins on the date of this Agreement and ends at 11:59 p.m., Eastern Time, on the [___]th calendar day following the first day on which the Company’s common stock trades on The Nasdaq Stock Market pursuant to the Direct Listing. If the Direct Listing has not occurred by [Outside Date], this Agreement terminates at 11:59 p.m., Eastern Time, on that date unless the parties agree in writing to extend it. This Agreement also terminates if the Company gives the Stockholder written notice that it has abandoned the Direct Listing.
3. Transfer Restrictions. During the Lock-Up Period, except as permitted by Section 4 or with the Company’s prior written consent, the Stockholder shall not, directly or indirectly:
(a) offer, sell, contract to sell, pledge, hypothecate, lend, grant any option or other right to purchase, or otherwise transfer, encumber or dispose of any Covered Securities or any interest therein;
(b) enter into any short sale, swap, hedge or other transaction that transfers to another person, in whole or in part, the economic consequences of ownership of any Covered Securities, whether settled by delivery of securities, in cash or otherwise; or
(c) publicly announce an intention to effect any transaction described in clause (a) or (b).
The registration of Covered Securities for resale under the Securities Act of 1933 does not release those securities from this Agreement.
4. Permitted Transfers. Section 3 does not prohibit a bona fide gift to a member of the Stockholder’s immediate family, a transfer to a trust for the benefit of the Stockholder or members of the Stockholder’s immediate family, or a transfer by will or the laws of descent and distribution. In each case, the transfer must be without consideration, and, before the Company registers the transfer, the transferee or the transferee’s legal representative must deliver to the Company a written agreement to be bound by the restrictions in this Agreement for the remainder of the Lock-Up Period. The conversion of Covered Securities into other securities of the Company is permitted if the securities received remain subject to this Agreement.
5. Transfer Agent Instructions. The Stockholder authorizes the Company to place stop-transfer instructions with its transfer agent and to decline to register any transfer of Covered Securities that would violate this Agreement. The Company may place a conspicuous legend on certificates representing Covered Securities or include notice of the restriction in the applicable notice for uncertificated shares. Upon expiration or termination of this Agreement or release of any Covered Securities, the Company shall promptly cause the corresponding stop-transfer instructions and any legend or notice imposed solely under this Agreement to be removed or updated, as applicable.
6. Stockholder Representations. The Stockholder represents that the ownership information in Schedule A is accurate as of the date of this Agreement and that the Stockholder has authority to agree to these restrictions with respect to the Covered Securities. The Stockholder shall cause any nominee holding Covered Securities on the Stockholder’s behalf to comply with this Agreement.
7. Waiver and Remedies. Any waiver or release by the Company must be in writing and signed by a duly authorized representative of the Company. The Company may seek injunctive relief or specific performance for a breach or threatened breach of this Agreement, in addition to any other remedies available at law or in equity. Expiration or termination does not affect liability for any prior breach.
8. Miscellaneous. Delaware law governs this Agreement without regard to conflict-of-laws principles. This Agreement binds the parties and their respective successors, heirs, legal representatives and permitted assigns. This Agreement constitutes the entire agreement between the parties with respect to the restrictions imposed by this Agreement and may be amended only by a writing signed by both parties. Any notice under this Agreement shall be in writing and delivered personally, by nationally recognized overnight courier, or by email with acknowledgment of receipt, to the applicable address below or to any replacement address designated by written notice. This Agreement may be executed in counterparts and by electronic signature, each of which shall be deemed an original.
| ZENO42 INC. | ||
| By: | ||
| Name: Ziad Youssef | ||
| Title: Director | ||
| 125 Park Avenue | ||
| New York, New York 10017 | ||
| Email: ziad.youssef@zeno42.com | ||
| STOCKHOLDER | ||
| By: | ||
| Torsten Lankau, individually | ||
| Dreischeibenhaus 1, 40211 | ||
| Dusseldorf, Germany. | ||
| Email: Torsten.Lankau@zeno42.com |
SCHEDULE A — COVERED SECURITIES
| Class or Series | Number of Shares | Name of Record Holder | ||
| ** ** | ** ** |